2015-2025 Global Parkinson's Disease Drug Market Research by Type, End-Use and Region (COVID-19)
SUMMARY
The global Parkinson's Disease Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Key Companies
The global Parkinson's Disease Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
- Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
- Chapter 2: Global Production & Consumption Market by Type and End-Use
- Chapter 3: Europe Production & Consumption Market by Type and End-Use
- Chapter 4: America Production & Consumption Market by Type and End-Use
- Chapter 5: Asia Production & Consumption Market by Type and End-Use
- Chapter 6: Oceania Production & Consumption Market by Type and End-Use
- Chapter 7: Africa Production & Consumption Market by Type and End-Use
- Chapter 8: Global Market Forecast by Type, End-Use and Region
- Chapter 9: Company information, Sales, Cost, Margin, news etc.
- Chapter 10: Market Competition by Companies and Market Concentration Ratio
- Chapter 11: Market Impact by Coronavirus.
- Chapter 12: Industry Summary
Key Companies
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Valeant Pharmaceuticals
- Sinemet-CR
- Trastal
- Madopar
- COMT Inhibitor
- Others
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaParkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Europe Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Europe Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Europe Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure America Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table America Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure America Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Asia Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Asia Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Asia Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Oceania Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Africa Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Africa Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Africa Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Parkinson's Disease Drug Production Forecast
Figure Global Parkinson's Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Parkinson's Disease Drug Forecast by Type
Table Global Parkinson's Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2025 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2025 (Volume)
8.3 Global Parkinson's Disease Drug Forecast by End-Use (2020E-2025F)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Parkinson's Disease Drug Forecast by Region (2020E-2025F)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Merck
9.1.1 Merck Profile
Table Merck Overview List
9.1.2 Merck Products & Services
9.1.3 Merck Company Dynamics & News
9.1.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Akorn
9.2.1 Akorn Profile
Table Akorn Overview List
9.2.2 Akorn Products & Services
9.2.3 Akorn Company Dynamics & News
9.2.4 Akorn Business Operation Conditions
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 GSK
9.3.1 GSK Profile
Table GSK Overview List
9.3.2 GSK Products & Services
9.3.3 GSK Company Dynamics & News
9.3.4 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Novartis
9.4.1 Novartis Profile
Table Novartis Overview List
9.4.2 Novartis Products & Services
9.4.3 Novartis Company Dynamics & News
9.4.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.5.2 Boehringer Ingelheim Products & Services
9.5.3 Boehringer Ingelheim Company Dynamics & News
9.5.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
9.6.2 Teva Pharmaceutical Products & Services
9.6.3 Teva Pharmaceutical Company Dynamics & News
9.6.4 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Abbvie
9.7.1 Abbvie Profile
Table Abbvie Overview List
9.7.2 Abbvie Products & Services
9.7.3 Abbvie Company Dynamics & News
9.7.4 Abbvie Business Operation Conditions
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Kyowa Hakko Kirin Pharma
9.8.1 Kyowa Hakko Kirin Pharma Profile
Table Kyowa Hakko Kirin Pharma Overview List
9.8.2 Kyowa Hakko Kirin Pharma Products & Services
9.8.3 Kyowa Hakko Kirin Pharma Company Dynamics & News
9.8.4 Kyowa Hakko Kirin Pharma Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Astellas Pharma
9.9.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
9.9.2 Astellas Pharma Products & Services
9.9.3 Astellas Pharma Company Dynamics & News
9.9.4 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Desitin Arzneimittel
9.10.1 Desitin Arzneimittel Profile
Table Desitin Arzneimittel Overview List
9.10.2 Desitin Arzneimittel Products & Services
9.10.3 Desitin Arzneimittel Company Dynamics & News
9.10.4 Desitin Arzneimittel Business Operation Conditions
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Endo Pharmaceuticals
9.11.1 Endo Pharmaceuticals Profile
Table Endo Pharmaceuticals Overview List
9.11.2 Endo Pharmaceuticals Products & Services
9.11.3 Endo Pharmaceuticals Company Dynamics & News
9.11.4 Endo Pharmaceuticals Business Operation Conditions
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 F.Hoffmann-La Roche
9.12.1 F.Hoffmann-La Roche Profile
Table F.Hoffmann-La Roche Overview List
9.12.2 F.Hoffmann-La Roche Products & Services
9.12.3 F.Hoffmann-La Roche Company Dynamics & News
9.12.4 F.Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
9.13 H.Lundbeck
9.13.1 H.Lundbeck Profile
Table H.Lundbeck Overview List
9.13.2 H.Lundbeck Products & Services
9.13.3 H.Lundbeck Company Dynamics & News
9.13.4 H.Lundbeck Business Operation Conditions
Table Business Operation of H.Lundbeck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Valeant
9.14.1 Valeant Profile
Table Valeant Overview List
9.14.2 Valeant Products & Services
9.14.3 Valeant Company Dynamics & News
9.14.4 Valeant Business Operation Conditions
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
9.15 Apokyn
9.15.1 Apokyn Profile
Table Apokyn Overview List
9.15.2 Apokyn Products & Services
9.15.3 Apokyn Company Dynamics & News
9.15.4 Apokyn Business Operation Conditions
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
9.16 Orion
9.16.1 Orion Profile
Table Orion Overview List
9.16.2 Orion Products & Services
9.16.3 Orion Company Dynamics & News
9.16.4 Orion Business Operation Conditions
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
9.17 Stada Arzneimittel
9.17.1 Stada Arzneimittel Profile
Table Stada Arzneimittel Overview List
9.17.2 Stada Arzneimittel Products & Services
9.17.3 Stada Arzneimittel Company Dynamics & News
9.17.4 Stada Arzneimittel Business Operation Conditions
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
9.18 US WorldMeds
9.18.1 US WorldMeds Profile
Table US WorldMeds Overview List
9.18.2 US WorldMeds Products & Services
9.18.3 US WorldMeds Company Dynamics & News
9.18.4 US WorldMeds Business Operation Conditions
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
9.19 Valeant Pharmaceuticals
9.19.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
9.19.2 Valeant Pharmaceuticals Products & Services
9.19.3 Valeant Pharmaceuticals Company Dynamics & News
9.19.4 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Parkinson's Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Parkinson's Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Parkinson's Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Parkinson's Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure America Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Asia Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Oceania Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Africa Parkinson's Disease Drug Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON PARKINSON'S DISEASE DRUG INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 PARKINSON'S DISEASE DRUG INDUSTRY SUMMARY & CONCLUSION
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaParkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Europe Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Europe Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Europe Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure America Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table America Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure America Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Asia Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Asia Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Asia Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Oceania Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Africa Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Africa Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Africa Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Parkinson's Disease Drug Production Forecast
Figure Global Parkinson's Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Parkinson's Disease Drug Forecast by Type
Table Global Parkinson's Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2025 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2025 (Volume)
8.3 Global Parkinson's Disease Drug Forecast by End-Use (2020E-2025F)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Parkinson's Disease Drug Forecast by Region (2020E-2025F)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Merck
9.1.1 Merck Profile
Table Merck Overview List
9.1.2 Merck Products & Services
9.1.3 Merck Company Dynamics & News
9.1.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Akorn
9.2.1 Akorn Profile
Table Akorn Overview List
9.2.2 Akorn Products & Services
9.2.3 Akorn Company Dynamics & News
9.2.4 Akorn Business Operation Conditions
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 GSK
9.3.1 GSK Profile
Table GSK Overview List
9.3.2 GSK Products & Services
9.3.3 GSK Company Dynamics & News
9.3.4 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Novartis
9.4.1 Novartis Profile
Table Novartis Overview List
9.4.2 Novartis Products & Services
9.4.3 Novartis Company Dynamics & News
9.4.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.5.2 Boehringer Ingelheim Products & Services
9.5.3 Boehringer Ingelheim Company Dynamics & News
9.5.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
9.6.2 Teva Pharmaceutical Products & Services
9.6.3 Teva Pharmaceutical Company Dynamics & News
9.6.4 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Abbvie
9.7.1 Abbvie Profile
Table Abbvie Overview List
9.7.2 Abbvie Products & Services
9.7.3 Abbvie Company Dynamics & News
9.7.4 Abbvie Business Operation Conditions
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Kyowa Hakko Kirin Pharma
9.8.1 Kyowa Hakko Kirin Pharma Profile
Table Kyowa Hakko Kirin Pharma Overview List
9.8.2 Kyowa Hakko Kirin Pharma Products & Services
9.8.3 Kyowa Hakko Kirin Pharma Company Dynamics & News
9.8.4 Kyowa Hakko Kirin Pharma Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Astellas Pharma
9.9.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
9.9.2 Astellas Pharma Products & Services
9.9.3 Astellas Pharma Company Dynamics & News
9.9.4 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Desitin Arzneimittel
9.10.1 Desitin Arzneimittel Profile
Table Desitin Arzneimittel Overview List
9.10.2 Desitin Arzneimittel Products & Services
9.10.3 Desitin Arzneimittel Company Dynamics & News
9.10.4 Desitin Arzneimittel Business Operation Conditions
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Endo Pharmaceuticals
9.11.1 Endo Pharmaceuticals Profile
Table Endo Pharmaceuticals Overview List
9.11.2 Endo Pharmaceuticals Products & Services
9.11.3 Endo Pharmaceuticals Company Dynamics & News
9.11.4 Endo Pharmaceuticals Business Operation Conditions
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 F.Hoffmann-La Roche
9.12.1 F.Hoffmann-La Roche Profile
Table F.Hoffmann-La Roche Overview List
9.12.2 F.Hoffmann-La Roche Products & Services
9.12.3 F.Hoffmann-La Roche Company Dynamics & News
9.12.4 F.Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
9.13 H.Lundbeck
9.13.1 H.Lundbeck Profile
Table H.Lundbeck Overview List
9.13.2 H.Lundbeck Products & Services
9.13.3 H.Lundbeck Company Dynamics & News
9.13.4 H.Lundbeck Business Operation Conditions
Table Business Operation of H.Lundbeck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Valeant
9.14.1 Valeant Profile
Table Valeant Overview List
9.14.2 Valeant Products & Services
9.14.3 Valeant Company Dynamics & News
9.14.4 Valeant Business Operation Conditions
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
9.15 Apokyn
9.15.1 Apokyn Profile
Table Apokyn Overview List
9.15.2 Apokyn Products & Services
9.15.3 Apokyn Company Dynamics & News
9.15.4 Apokyn Business Operation Conditions
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
9.16 Orion
9.16.1 Orion Profile
Table Orion Overview List
9.16.2 Orion Products & Services
9.16.3 Orion Company Dynamics & News
9.16.4 Orion Business Operation Conditions
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
9.17 Stada Arzneimittel
9.17.1 Stada Arzneimittel Profile
Table Stada Arzneimittel Overview List
9.17.2 Stada Arzneimittel Products & Services
9.17.3 Stada Arzneimittel Company Dynamics & News
9.17.4 Stada Arzneimittel Business Operation Conditions
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
9.18 US WorldMeds
9.18.1 US WorldMeds Profile
Table US WorldMeds Overview List
9.18.2 US WorldMeds Products & Services
9.18.3 US WorldMeds Company Dynamics & News
9.18.4 US WorldMeds Business Operation Conditions
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
9.19 Valeant Pharmaceuticals
9.19.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
9.19.2 Valeant Pharmaceuticals Products & Services
9.19.3 Valeant Pharmaceuticals Company Dynamics & News
9.19.4 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Parkinson's Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Parkinson's Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Parkinson's Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Parkinson's Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure America Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Asia Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Oceania Parkinson's Disease Drug Market Concentration Ratio in 2020E
Figure Africa Parkinson's Disease Drug Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON PARKINSON'S DISEASE DRUG INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 PARKINSON'S DISEASE DRUG INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Akorn Overview List
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Pharma Overview List
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Desitin Arzneimittel Overview List
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F.Hoffmann-La Roche Overview List
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
Table H.Lundbeck Overview List
Table Business Operation of H.Lundbeck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Overview List
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
Table Apokyn Overview List
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
Table Orion Overview List
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
Table Stada Arzneimittel Overview List
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
Table US WorldMeds Overview List
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
Table Valeant Pharmaceuticals Overview List
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Parkinson's Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Parkinson's Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Parkinson's Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Parkinson's Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
Table Global Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Parkinson's Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Parkinson's Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Parkinson's Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Parkinson's Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Global Parkinson's Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Table Global Parkinson's Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Parkinson's Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Parkinson's Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Akorn Overview List
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Pharma Overview List
Table Business Operation of Kyowa Hakko Kirin Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Desitin Arzneimittel Overview List
Table Business Operation of Desitin Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F.Hoffmann-La Roche Overview List
Table Business Operation of F.Hoffmann-La Roche (Sales Revenue, Cost, Gross Margin)
Table H.Lundbeck Overview List
Table Business Operation of H.Lundbeck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Overview List
Table Business Operation of Valeant (Sales Revenue, Cost, Gross Margin)
Table Apokyn Overview List
Table Business Operation of Apokyn (Sales Revenue, Cost, Gross Margin)
Table Orion Overview List
Table Business Operation of Orion (Sales Revenue, Cost, Gross Margin)
Table Stada Arzneimittel Overview List
Table Business Operation of Stada Arzneimittel (Sales Revenue, Cost, Gross Margin)
Table US WorldMeds Overview List
Table Business Operation of US WorldMeds (Sales Revenue, Cost, Gross Margin)
Table Valeant Pharmaceuticals Overview List
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Parkinson's Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Parkinson's Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Parkinson's Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Parkinson's Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaParkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Europe Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Europe Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure America Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure America Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Asia Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Asia Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Oceania Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Africa Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Africa Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Parkinson's Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2025 (Million USD)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2025 (Volume)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Volume Share by Region in 2025 (Volume)
Figure Europe Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaParkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Parkinson's Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Parkinson's Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Europe Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Europe Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure America Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure America Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Asia Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Asia Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Oceania Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Parkinson's Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Africa Parkinson's Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Africa Parkinson's Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Parkinson's Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Parkinson's Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Parkinson's Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Parkinson's Disease Drug Revenue Share by Type in 2025 (Million USD)
Figure Global Parkinson's Disease Drug Production Volume Share by Type in 2025 (Volume)
Figure Global Parkinson's Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Figure Global Parkinson's Disease Drug Consumption Volume Share by Region in 2025 (Volume)
